Cambridge Investment Research Advisors, Inc. Gossamer Bio, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 19,300 shares of GOSS stock, worth $24,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,300
Previous 16,000
20.63%
Holding current value
$24,318
Previous $14,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
162MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$23.1 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$22.8 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$12.7 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.2 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA6.36MShares$8.01 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $118M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...